Skip to content
Sign in

JDOC · NASDAQ · ETF

JPMorgan Healthcare Leaders ETF (JDOC) Price, Holdings & Fees

$280.70+1.51%+$4.18End-of-day price as of Oct 9, 2026

JPMorgan Healthcare Leaders ETF (JDOC) closed at $280.70 on Oct 9, 2026, up 1.51% from the previous close of $276.52.

Share price, past year

1Y −9.46%

52-week range $275.55 – $329.61. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$280.70
Sep 30, 2026$286.59
Aug 31, 2026$297.76
Jul 31, 2026$299.49
Jun 30, 2026$298.24
May 29, 2026$305.99
Apr 30, 2026$302.74
Mar 31, 2026$320.44
Feb 27, 2026$321.75
Jan 30, 2026$304.29
Dec 31, 2025$306.12
Nov 28, 2025$311.41
Oct 31, 2025$305.84

Key statistics

Expense ratio
0.65%
as of Oct 31, 2025
Net assets
$9.1M
as of Jul 31, 2026
Holdings
61
as of Jul 31, 2026
52-week range
$275.55 – $329.61

JPMorgan Healthcare Leaders ETF's expense ratio is 0.65%: $65.00 a year on $10,000 invested.

Holdings

JPMorgan Healthcare Leaders ETF held 61 investments worth $9.07M as of Jul 31, 2026. Its largest holding was AbbVie, Inc., at 7.85% of the fund.

JPMorgan Healthcare Leaders ETF largest holdings by share of net assets
#Holding% of fundValue
1AbbVie, Inc.7.85%$712.17K
2Eli Lilly & Co.7.76%$704.24K
3UnitedHealth Group, Inc.5.85%$530.85K
4Merck & Co., Inc.4.82%$437.34K
5Johnson & Johnson4.82%$437.33K
6AstraZeneca plc3.76%$460.14K
7Thermo Fisher Scientific, Inc.3.73%$338.84K
8Bristol-Myers Squibb Co.3.57%$324.07K
9Abbott Laboratories3.11%$282.11K
10CVS Health Corp.2.83%$256.69K
11Roche Holding AG2.82%$316.82K
12Novo Nordisk A/S2.61%$36.59K
13GSK plc2.47%$301.57K
14Stryker Corp.2.23%$201.93K
15Danaher Corp.2.16%$196.15K
16Cencora, Inc.2.07%$188.05K
17Argenx SE2.06%$215.31K
18Intuitive Surgical, Inc.1.93%$175.25K
19Edwards Lifesciences Corp.1.73%$157.25K
20IQVIA Holdings, Inc.1.71%$155.35K
21Teva Pharmaceutical Industries Ltd.1.60%$47.54K
22Regeneron Pharmaceuticals, Inc.1.60%$144.90K
23Novartis AG1.60%$179.13K
24Biogen, Inc.1.56%$141.86K
25Cardinal Health, Inc.1.51%$137.33K

Top 25 of 61 holdings, as of Jul 31, 2026. Percentages are of the fund's net assets.

What the fund owns

JPMorgan Healthcare Leaders ETF holdings by asset type
Asset type% of fund
Stocks99.20%
JPMorgan Healthcare Leaders ETF holdings by country, largest 10
Country% of fund
United States75.20%
United Kingdom6.23%
Switzerland4.42%
Denmark4.03%
Japan2.47%
Netherlands2.36%
Germany1.86%
Israel1.60%
Cayman Islands0.69%
Ireland0.35%

Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.

Monthly total returns

Over the 3 months to Jul 31, 2026, JPMorgan Healthcare Leaders ETF's total return was +8.75%, as reported to the SEC.

JPMorgan Healthcare Leaders ETF monthly total returns
MonthTotal return
Jul 31, 2026+0.47%
Jun 30, 2026+6.38%
May 31, 2026+1.76%

The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.

Fund profile

Name
JPMorgan Healthcare Leaders ETF
Ticker
JDOC
Exchange
NASDAQ
Fund type
ETF
Trust
J.P. Morgan Exchange-Traded Fund Trust
SEC series ID
S000080528
SEC CIK
0001485894
Fractional shares
No

Recent SEC filings

Shareholder reports and prospectuses are filed by J.P. Morgan Exchange-Traded Fund Trust, the trust behind JPMorgan Healthcare Leaders ETF, and cover all of its funds.

Frequently asked questions

What is JDOC's price?

JPMorgan Healthcare Leaders ETF (JDOC) closed at $280.70 on Oct 9, 2026, up 1.51% from the previous close of $276.52.

What is JDOC's expense ratio?

JPMorgan Healthcare Leaders ETF's expense ratio is 0.65%: $65.00 a year on $10,000 invested.

What does JDOC hold?

JPMorgan Healthcare Leaders ETF held 61 investments worth $9.07M as of Jul 31, 2026. Its largest holding was AbbVie, Inc., at 7.85% of the fund. Its five largest holdings were AbbVie, Inc., Eli Lilly & Co., UnitedHealth Group, Inc., Merck & Co., Inc., Johnson & Johnson.

How has JDOC performed?

Over the 3 months to Jul 31, 2026, JPMorgan Healthcare Leaders ETF's total return was +8.75%, as reported to the SEC.

Sources and methodology

Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jul 31, 2026 (filed Sep 28, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Oct 31, 2025. Prices are generated sample data for development. Data sources and disclosures